Fundraising FoxPolaris Partners — 2026 Investments
5 investments dated 2026 · listed companies and verified rows first · show all
ByHeart is an infant formula company that manufactures science-driven baby formula with its own manufacturing process and supply chain.
ConsumerDirect to ConsumerFoodTechHealthtechNew York, US
Ron Belldegrun(Co-founder)inMia Funt(Founder)inGeorg Krause-Vilmar(Executive Officer)inNiall Mullane(Executive Officer)in
BoardHemi Zucker(Director)in
Board seatAmy Schulman· per SEC Form D
Co-investorsEvolution VC PartnersGaingelsOCV PartnersRed Sea VenturesAF VenturesVida Ventures
__Twitter.png)
Lob provides software and hardware infrastructure for automating, personalizing, and tracking direct mail campaigns at scale.
Enterprise SoftwareLogistics & Supply ChainMarketing TechSaaSNew York City, US
Harry Zhang(Founder)inLeore Avidar(Founder)inEduardo Browne(Executive Officer)Donnell Vanker(Executive Officer)Ryan Ferrier(Chief Executive Officer)inAnna Donavan
Co-investorsFirst Round CapitalFloodgateFrontline VenturesFundersClubInitialized CapitalSaints Capital+22 more
Tavo Biotherapeutics develops novel treatments for glaucoma and retinal diseases, focusing on disease-modifying therapies that target the root biological mechanisms of vision loss.
BiotechHealthtechMedical Devices
Co-investorsPureos Bioventures
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Sea PharmaceuticalsTropic
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.